Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced the purchase of 236,167 of its ordinary shares, each with a nominal value of 31¼ pence, on August 28, 2025. The shares were bought through Merrill Lynch International, acting as its corporate stockbroker. The lowest price paid per share was 1,460.50p, while the highest price reached 1,479.00p, resulting in a volume-weighted average price of 1,466.11p per share. These shares will be held in treasury, as part of an existing buyback program. Since June 4, 2025, GSK has purchased a total of 26,021,500 ordinary shares. Following this transaction, the company's treasury will hold 244,155,883 ordinary shares, with 4,071,236,744 ordinary shares in issue excluding treasury shares; treasury shares represent 6.00 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today